Senat-Gremium genehmigt CDC-Nominierten, umstrittenen HHS wählen

The Senate health committee approved the nomination of Erica Schwartz for director of the Centers for Disease Control and Prevention (CDC) and Sean Kaufman for assistant secretary for preparedness and response (ASPR) on Thursday. These confirmations represent a critical step in filling key positions within the Trump administration's health infrastructure, which has long struggled with staffing shortages and ideological conflicts. Both nominees now await final approval by the full Senate, although no specific dates have been announced for such votes. The committee's decisions reflect a willingness among Republican members to support the administration despite concerns over the qualifications and past statements of some candidates. The vote on Erica Schwartz passed 12-10, with all Republicans and one Democrat supporting her nomination. For Sean Kaufman, the vote was closer, 12-11, with all Republicans backing him and all Democrats opposing. Committee chairman Bill Cassidy (R-La.) voiced reservations about Kaufman's past anti-vaccine comments but ultimately supported the nomination after receiving assurances from the Department of Health and Human Services (HHS). According to Cassidy, HHS officials promised unspecified personnel changes and a commitment to keep Kaufman away from vaccine-related policymaking. Cassidy acknowledged that Kaufman had previously made "stupid and irresponsible" remarks about immunizations but emphasized that he had since taken responsibility for those views. The senator stressed that he would monitor future actions to ensure that science, not ideology, guides decision-making. He also warned that the committee might exert influence over future appointments if these commitments are not honored. Erica Schwartz, who served as deputy surgeon general under the first Trump administration, faced scrutiny during her July 15 confirmation hearing. She was questioned about her ability to avoid political interference and her plans for revitalizing the CDC, which has suffered from low morale and staffing issues due to prolonged leadership gaps. Schwartz pledged to prioritize scientific integrity and rebuild public trust in the agency. However, she remained vague about whether she would inform Congress if directed to implement unscientific or harmful policies, stating she believed neither President Trump nor Health Secretary Robert F. Kennedy Jr. would pursue such measures. Schwartz succeeded Susan Monarez, who was removed from her position after just days in office, reportedly for refusing to endorse Kennedy's vaccine policies. Her appointment marks a shift toward a less polarizing figure compared to previous Trump health nominees. Public health experts suggest she faces considerable challenges in restoring stability to the CDC amid ongoing controversies surrounding vaccine safety and misinformation. Sean Kaufman's nomination drew particular controversy due to his history of expressing skepticism about vaccines. His past statements, initially reported by STAT, raised concerns about his suitability for a role responsible for pandemic preparedness. Despite these reservations, Cassidy decided to support Kaufman after negotiations with HHS officials, who reportedly offered assurances about limiting his involvement in vaccine policy. However, the effectiveness of these assurances remains uncertain, especially given previous instances where HHS has deviated from commitments made to Cassidy. The broader context includes ongoing tensions between Cassidy and HHS leadership, particularly Health Secretary Robert F. Kennedy Jr. Earlier agreements between the two have been partially broken, including the removal of a panel of vaccine advisers and the appointment of individuals skeptical of vaccines. Additionally, HHS has proposed reducing the number of recommended pediatric vaccines, a move Cassidy opposes. Changes to the CDC's website, which previously stated vaccines do not cause autism, have also drawn criticism, with Cassidy calling the revisions insufficient. As the full Senate prepares to consider the nominations, the focus remains on ensuring that the confirmed officials adhere to the commitments made during the confirmation process. The outcome of these votes will have implications for the direction of U.S. public health policy, particularly in addressing current health challenges such as measles outbreaks and foodborne illnesses. Meanwhile, the committee continues to evaluate other nominees, including Nicole Saphier for surgeon general, whose stronger support for vaccines has been noted as encouraging.